$ETSY

Buckley Merilee sold $66K of ETSY

Buckley Merilee (CHIEF ACCOUNTING OFFICER) sold 881 shares of ETSY INC (ETSY) at an average of $75.35 ($75.09–$77.14) across 3 trades on 2026-07-06 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Buckley Merilee
Published Jul 8, 2026, 8:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 8, 2026, 8:21 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ETSY
Neutral
high confidence
Mentioned
$ETSY
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ETSYNeutralLow
01

Why it matters

Traders may monitor for patterns of insider activity, but this single scheduled sale provides limited incremental information about near-term fundamentals.

02

Market read

A routine 10b5-1 insider sale is disclosed; it is more relevant for sentiment monitoring than for a fresh fundamental thesis.

03

What to watch

The article does not disclose any offsetting insider buys, changes in guidance, or other fundamental updates, limiting interpretability for trading decisions.

Relevance 2/10Novelty 3/10Timing: Filed 2026-07-08, discloses trades executed 2026-07-06.

Background

The article is an SEC Form 4 insider transaction disclosure for Etsy, reported by the Chief Accounting Officer.

Company-level read

Ticker impact

$ETSYNeutralHigh confidence
Context

SEC Form 4 shows Etsy CFO Buckley Merilee sold 881 shares in open-market trades on 2026-07-06 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move; any reaction is likely brief and sentiment-driven.

Evidence & confidence

The filing is a Form 4 insider sale with a stated pre-arranged 10b5-1 plan, and the article provides no new company-specific operational or financial information.

Market effects

Minimal, as this is company-specific insider transaction data with no sector-wide signal.

None indicated.

None indicated.

Counterpoint

Insider sales under a 10b5-1 plan often reflect diversification or scheduled liquidity needs rather than bearish expectations.

Key entities

  • ETSY

    Issuer of the Form 4 insider transaction disclosure.

  • Buckley Merilee

    Chief Accounting Officer who sold shares in open-market trades under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$WMTMed

Retailers Report AI-Driven Sales, Bigger Baskets in Q2 Earnings

Walmart, Amazon, and Target reported Q2 earnings showing AI-driven sales growth. Walmart's eCommerce grew 23%, with AI assistant users spending 40% more. Amazon's Alexa for Shopping saw active users nearly double. Target's digital traffic from AI platforms grew over 3.5x faster than the industry average. Albertsons saw a 10-26% increase in order value with AI tools. Shopify's AI-referred traffic and orders tripled, but AI's impact on discovery-driven retail remains uncertain.

$ETSYHigh

Bank of America Resets Etsy Stock Price Target After Event

Bank of America upgraded Etsy to Buy, raising its price target to $105 from $88, citing structural growth. The bank expects mid-single-digit gross merchandise sales growth, higher profitability, and increased shareholder returns. Etsy's new management team is seen as key to reinvigorating growth. BofA raised its fiscal 2027 estimates for gross merchandise sales, EBITDA, and EPS.

$DEMed

Premarket movers: Deere jumps following upbeat Q3, Wolfspeed plunges

Deere shares rose 5.1% after reporting stronger-than-expected Q3 results, with EPS of $5.10 and net sales of $11B. CrowdStrike fell 2.8% following its CTO's departure. Advance Auto Parts dropped 15.9% due to lower normalized earnings. Etsy gained 3.9% after a BofA upgrade. Ultragenyx surged 11.1% on FDA approval for a gene therapy. Moderna fell 13% after a prior surge. Wolfspeed plunged 10.5% on wider-than-expected Q4 loss. Webull rose 13.8% on strong Q2 results.